Anti-obesity compounds in green leaves of Eucommia ulmoides

Bioorganic and Medicinal Chemistry Letters

Volumn 21, Issue 6, 2011, Pages 1786-1791

  Hirata, T ^a   Kobayashi, T ^a   Wada, A ^a   Ueda, T ^a   Fujikawa, T ^b,c   Miyashita, H ^d   Ikeda, T ^e   Tsukamoto, S ^e   Nohara, T ^d  

^a Kobayashi Pharmaceutical Co   (Japan)

^b SUZUKA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d SOJO UNIVERSITY   (Japan)

^e KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Anti obesity; Asperuloside; Chronic high dose administration; Eucommia ulmoides Oliv.; Iridoid

Indexed keywords

ASPERULOSIDE; CHLOROGENIC ACID; CHOLESTEROL; EUCOMMIA ULMOIDES EXTRACT; FATTY ACID; GENIPOSIDIC ACID; PLANT MEDICINAL PRODUCT; POLYSTYRENE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASAL METABOLIC RATE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; FATTY ACID OXIDATION; GLUCOSE METABOLISM; LIPID DIET; LIPID METABOLISM; METABOLIC SYNDROME X; MOUSE; NONHUMAN; OBESITY; PLANT LEAF; RESPIRATORY QUOTIENT; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE; ANIMALS; ANTI-OBESITY AGENTS; BODY WEIGHT; CHOLESTEROL; EUCOMMIACEAE; MICE; ORGAN SIZE; PLANT LEAVES; TRIGLYCERIDES;

EUCOMMIA; EUCOMMIA ULMOIDES; MUS;

EID: 79952360200     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2011.01.060     Document Type: Article

References (27)

1. Y. Nakazawa, N. Odagiri, R. Imai, T. Yoshii, E. Tagashira, C. Nakata, T. Nakamura, M. Asaumi, S. Onizuka, C. Tanaka, S. Yahara, and T. Nohara Nat. Med. 51 1997 392
2. K. Kawasaki, K. Uezono, and Y. Nakazawa J. Health Sci. 22 2000 29
3. T. Fujikawa, T. Hirata, A. Wada, N. Kawamura, Y. Yamaguchi, K. Fujimura, T. Ueda, Y. Yurugi, H. Soya, and S. Nishibe Br. J. Nutr. 104 2010 1868
4. Y. Matsuzawa Atheroscler. Suppl. 6 2005 7
5. Chinese Materia Medica Dictionary, Jiangsu New Medical College, ed. Shanghai Science and Technology Publishing House: Shanghai; 1977, p 1031.
6. T. Nakamura, Y. Nakazawa, S. Onizuka, C. Tanaka, S. Yahara, and T. Nohara Nat. Med. 51 1997 275
7. H. Li, B. Chen, and S. Yao Ultrason Sonochem. 12 2005 295
8. C. Takamura, T. Hirata, Y. Yamaguchi, T. Ueda, M. Ono, H. Miyashita, T. Ikeda, and T. Nohara J. Nat. Med. 61 2007 220
9. C. Takamura, T. Hirata, T. Ueda, M. Ono, H. Miyashita, T. Ikeda, and T. Nohara J. Nat. Prod. 70 2007 1312
10. T. Namba, Y. Hattori, J.N. Yie, Y.H. Ma, Y. Nomura, S. Kaneko, Y. Kitamura, T. Koizumi, K. Katayama, and W. Lu J. Tradit. Med. 3 1986 89
11. Y. Nomura, S. Kaneko, Y. Kitamura, T. Namba, M. Tohda, M. Hattori, and J. Yie J. Trad. Med. 3 1986 328
12. K. Metori, S. Ohashi, S. Takahashi, and T. Tamura Biol. Pharm. Bull. 17 1994 917
13. M.S. Choi, U.J. Jung, H.J. Kim, G.M. Do, S.M. Jeon, M.J. Kim, and M.K. Lee Am. J. Chin. Med. 36 2008 81
14. X. Jin, K. Amitani, Y. Zamami, S. Takatori, N. Hobara, N. Kawamura, T. Hirata, A. Wada, Y. Kitamura, and H. Kawasaki J. Ethnopharmacol. 128 2010 672
15. C. Ando, T. Kobayashi, S. Tsukamoto, T. Hirata, Y. Yamaguchi, and T. Ueda Int. Symp. Eucommia ulmoides 1 2007 63
16. 2O fractions (Fr. 1; 4.52 kg), 30% MeOH fractions (Fr. 2; 432 g), 50% MeOH fractions (Fr. 3; 215 g), 80% MeOH fractions (Fr. 4; 76.7 g) and 100% MeOH fractions (Fr. 5; 2.4 g), in the order of elution.
17. Female ICR mice (4 weeks old; 23-28 g) purchased from SLC, Inc. (Shizuoka, Japan) were maintained at a temperature of 23-26 °C, relative humidity of 40-60%, and a 12-h light-dark cycle (lights on at 8 AM and off at 8 PM) for 1 week after arrival. Mice were divided into groups (n = 8) based on body weight. The experimental diet consisted of 40% beef tallow, 36% casein, 9% granulated sugar, 4% mineral mixture, 1% vitamin mixture, 10% cornstarch, and test materials (beef tallow, casein, granulated sugar, mineral mixture, vitamin mixture, cornstarch; Oriental Yeast Co., Ltd, Tokyo, Japan). The high-fat diet (HFD) group received feed in which one of the test materials was replaced by 10% casein.
18. For determination of the major components (geniposidic acid, asperuloside and chlorogenic acid) in the samples, an HPLC system comprised of a YMC-Pack ODS column (YMC Co., Ltd, Kyoto, Japan; 6.0 × 150 mm, 5 μm), LC-10AT pumps, and a SPD-10A UV detector (Shimazu Co., Ltd, Kyoto, Japan) was assembled. The mobile phase was methanol/water/phosphoric acid (870:130:1, v/v) at a flow rate of 1.0 ml/min. The detection wavelength was 215 nm.
19. Test materials were prepared by adding 10% EGLP, 7.97% Fr. 1, 0.76% Fr. 2, 0.38% Fr. 3, 0.14% Fr. 4 and 0.004% Fr. 5.
20. After 4 weeks of administration, body weight was measured and mice were sacrificed by decapitation without loading stress. Blood was collected immediately after the animals had been sacrificed by decapitation. The blood was centrifuged (3000 rpm, 30 min), and the separated plasma was stored at -80 °C until measurement. The levels of plasma TG and plasma total cholesterol were measured using commercially available enzyme kits (triglyceride: E-Test Wako, cholesterol: E-Test Wako; Wako Pure Chemicals Industries, Ltd, Osaka, Japan). Levels of FFA were measured using commercially available enzyme kits (FFA kit: Wako Pure Chemicals Industries, Ltd, Osaka, Japan). White adipose tissues (WAT) (abdominal visceral fat) were immediately removed. All procedures were carried out in accordance with the Guidelines for Animal Experiments at Kobayashi Pharmaceutical Co., Ltd, R & D Center, the Japanese Government Animal Protection and Management Law (No. 105), and the Japanese Government Notification on Feeding and Safekeeping of Animals (No. 6).
21. Differences between groups were assessed with the unpaired Tukey t-test using a statistical package from the spss13.0 program. Differences were considered significant at p <0.05.
22. T. Yamauchi, J. Kamon, H. Waki, K. Murakami, K. Motojima, K. Komeda, T. Ide, N. Kubota, Y. Terauchi, K. Tobe, H. Miki, A. Tsuchida, Y. Akanuma, R. Nagai, S. Kimura, and T. Kadowaki J. Biol. Chem. 276 2001 1796
23. T. Yamauchi, J. Kamon, H. Waki, Y. Terauchi, N. Kubota, K. Hara, Y. Mori, T. Ide, K. Murakami, N. Tsuboyama-Kasaoka, O. Ezaki, Y. Akanuma, O. Gavrilova, C. Vinson, M.L. Reitman, H. Kagechika, K. Shudo, M. Yoda, Y. Nakano, K. Tobe, R. Nagai, S. Kimura, M. Tomita, P. Froguel, and T. Kadowaki Nat. Med. 7 2001 941
24. T. Yamauchi, J. Kamon, Y. Minokoshi, Y. Ito, H. Waki, S. Uchida, S. Yamashita, M. Noda, S. Kita, K. Ueki, K. Eto, Y. Akanuma, P. Froguel, F. Foufelle, P. Ferre, D. Carling, S. Kimura, R. Nagai, B.B. Kahn, and T. Kadowaki Nat. Med. 8 2002 1288
25. 2O-MeOH (1:1-6:1) and then purified by Daisogel SP-120-40/60-ODS-B (100 × 1000 mm) eluted with 80% MeOH, vacuum-dried and freeze-dried, and washed with acetone to furnish asperuloside (31.3 g, purity 99.5%). Geniposidic acid and asperuloside were extracted and isolated from EGLP.
26. Test materials were prepared by adding 0.63% geniposidic acid, 0.45% asperuloside, and 0.44% chlorogenic acid.
27. A.S. Cho, S.M. Jeon, M.J. Kim, J. Yeo, K.I. Seo, M.S. Choi, and M.K. Lee Food Chem. Toxicol. 48 2010 937